NCT03920436 is a NA clinical trial of infrared water group in Metabolic Problems, sponsored by Pusan National University Yangsan Hospital.

Who is sponsoring NCT03920436?

NCT03920436 is sponsored by Pusan National University Yangsan Hospital.

What drugs are being tested in NCT03920436?

Interventions in NCT03920436: infrared water group, sham group.

What condition does NCT03920436 study?

NCT03920436 studies Metabolic Problems.

Is NCT03920436 still recruiting?

NCT03920436 is currently completed. Last updated 11 September 2019.

Last reviewed 2019-09-11 · How we verify

NCT03920436

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Oral Ingestion of Drinking Water Using a Tumbler That Emits Far Infrared Rays on Metabolic Profile

Completed NA Last updated 11 September 2019

What this trial tests

NA trial testing infrared water group in Metabolic Problems in 30 participants. Completed in 31 July 2019.

Timeline

1 February 2019

Primary endpoint
1 July 2019

31 July 2019

Quick facts

Lead sponsor	Pusan National University Yangsan Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	1 February 2019
Primary completion	1 July 2019
Estimated completion	31 July 2019
Sites	1 location across South Korea

Drugs / interventions tested

infrared water group
sham group

Conditions studied

Metabolic Problems — all drugs for Metabolic Problems →

Sponsor

Pusan National University Yangsan Hospital

Who can join

19 and older, any sex, with Metabolic Problems. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of oral ingestion of drinking water using a tumbler that emits far infrared rays at room temperature on metabolic profile in adults for 8 weeks.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Late-Breaking Abstracts for ECO2022.
· 2022 · cited 1× · PMID 35500565 · DOI 10.1159/000524649

Verify or expand the search:

Other Pusan National University Yangsan Hospital trials

Trials by the same sponsor.

NCT07511634 — Comparison of Sevoflurane and Desflurane on ANI in Patients Undergoing General Anesthesia: a Prospective Randomized Cont · NA · not yet recruiting
NCT07324226 — Effects of Combined Heat Application and Acupressure to the Carotid Artery Region on Cerebral Blood Flow in Healthy Adul · NA · recruiting
NCT07334327 — Extracorporeal Blood Purification Using Oxiris for Septic Shock (EXPLORE Study) · NA · not yet recruiting
NCT07323823 — The Effect of PBM on the Electrical Activity of the Brain in Stroke Patients · NA · not yet recruiting
NCT07447271 — Ultrasound Guided Cervical Selective Nerve Root Block Versus Fluoroscopic Guided Cervical Transforaminal Epidural Block · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03920436 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pusan National University Yangsan Hospital
Last refreshed: 11 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03920436.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing